Skip to content

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06213415
Enrollment
42
Registered
2024-01-19
Start date
2024-02-29
Completion date
2026-11-30
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell Palsy

Brief summary

intratympanic steroid injection bell's palsy

Detailed description

Role of oral steroid alone versus oral steroid plus intratympanic steroid injection in Bell's palsy

Interventions

DRUGCorticosteroid

Oral steroids plus intratympanic injection

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mean Aged 18 years or more. * Acute unilateral facial palsy without skin lesions which developed within a 72-hour period and is present for 21 days or less. * Moderate to severe facial palsy \[House-Brackmann grade IV or greater\]

Exclusion criteria

* Another cause of facial nerve paralysis that is not idiopathic. * Otologic disease including otitis media, temporal bone fracture, a previous history of facial nerve palsy in either side, history of otologic surgery, and suspected Ramsay Hunt syndrome. * Systemic disease including history of tuberculosis, history of head and neck cancer, other neurological disorders, recent use of ototoxic medications, liver or renal dysfunction, and other illnesses that would contraindicate the use of high-dose steroid therapy. * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Success or failure of procedure to treat Bell's palsy6 monthsDegree of regaining function to facial nerve Unit of measurement : nerve conduction study Measurement tool :endoscopic injection by ear microscope

Contacts

Primary ContactAhmed Mohamed Alaa
Drahmedm.alaaa@gmail.com01007575074
Backup ContactHussein Farid mostafa wishahi
hussien.weshahi@med.au.edu.eg01001775898

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026